Under the two-slab GST structure, multiple medicines are likely to get cheaper as they won't be taxed. Medicines on which GST has been cut from 5% to nil include Agalsidase Beta, Imiglucerase and Eptacog alfa activated recombinant coagulation factor VIIa. Those whose GST has been reduced from 12% to zero include Asciminib, Mepolizumab, Daratumumab, Teclistamab, Risdiplam, Alectinib and Laronidase.